Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. COVID Testing Kits
  6. 23312208

Roche Diagnostics cobas Liat SARS-CoV-2 Control Kit

Catalog No. 23312208 Shop All Roche Diagnostics Products
Change view
Click to view available options
Detectable Analytes:
ORF 1a/b and N gene SARS-CoV-2
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Detectable Analytes
23-312-208 ORF 1a/b and N gene SARS-CoV-2
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.
Catalog No. 23-312-208 Supplier Roche Diagnostics Supplier No. 09408835190
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.

Description

Nucleic acid test for use on cobas Liat system is the first real-time RT-PCR test authorized for use in screening and testing asymptomatic/symptomatic individuals for SARS-CoV-2 at the point of care, for running a control test/lot validation for the assay

  • Screen asymptomatic individuals to help prevent the silent spread of SARS-CoV-2
  • Provide answers patients need in 20 min. enabling quick actions to manage patient care
  • Offers broad strain coverage of SARS-CoV-2 variants
TRUSTED_SUSTAINABILITY

Specifications

Content And Storage 2°C to 8°C
Detectable Analytes ORF 1a/b and N gene SARS-CoV-2
Format Kit
For Use With (Equipment) Cobas™ Liat system analyzer and assays
Sample Type Nasopharyngeal Swab, Mid Turbinate Swab, Nasal Swab
Target Organism Class Dual-target ORF 1a/b & N gene SARS-CoV-2
Technology RT-PCR
Type Control Kit
Disposable Single-use
For Use With (Application) Rapid in vitro qualitative detection of nucleic acid from SARS-CoV-2 in self-collected anterior nasal swabs and healthcare provider-collected nasopharyngeal, mid-turbinate and anterior nasal swabs from either individuals suspected of COVID-19
Includes 3 sets of positive and negative controls
Product Line Roche Diagnostics Cobas™ SARS-CoV-2
Shipping Condition Cold chain
Sterility Non-sterile
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.